Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT05007613 · COMPLETED
Trial details
- NCT number
- NCT05007613
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-23
- Primary completion
- 2024-07-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.